Bibliographic record

Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east…

Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S. The Lancet Diabetes & Endocrinology 2022

Document identifier: CEI-BR-055
Series: Bibliographic record
Version: 1.0
Published: 30 Jul 2026
Last reviewed: 30 Jul 2026
Certainty: Not rated

§1Bibliographic record

§1.1Record

Authors: Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S
Title: Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Source: The Lancet Diabetes & Endocrinology
Year: 2022
Volume, issue, pages: 10(3):193–206
Digital object identifier: 10.1016/S2213-8587(22)00008-0
PubMed identifier: 35131037
Record type: Journal article
Institute identifier: CEI-BR-055

§1.2Institute documents citing this record

No Institute document currently cites this record. It is held in the bibliography because it was retrieved during a search and assessed, and the Institute records what it assessed and did not use as well as what it used.

§1.3Subject tags

semaglutide east-asian STEP

Compound Evidence Institute · CEI-BR-055 · https://compoundevidence.com/bibliography/kadowaki2022/ · retrieved 30 July 2026